Episode 17. Acquired Aplastic Anemia
Blood Cancer Talks
The Risk of Secondary Myelornia Plasms in Plastic Anemia
The risk after immunosuppressive therapy of secondary myeloid neoplasms has remained very real and very consistent. It's usually, depending on the series, between 10 and 20%. And the article that you refer to, which is some really beautiful work from Carmelo Granari in Yark Matsuyeski's lab, looked at a super large multi for a plastic anemia. These are rare diseases. Yeah, thousand patients, that's it. That's a big, big core. The median follow up was a little over eight and a half years.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
